Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated May 15, 2019. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q1 2019. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 17.4B USD
- Positions
- 57
- Share of the ten largest
- 51.4%
The ten largest positions Q1 2019
- Elevance Health 10.2%▲ +21.5%
- Microsoft 6.6%▼ −25.8%
- Alibaba Group (ADR) 6.0%▼ −43.7%
- UnitedHealth Group 5.3%▲ +31.1%
- United Technologies Corp 5.2%▲ +1.5%
- Marathon Petroleum 4.7%▲ +3.8%
- Netflix 4.1%▼ −34.0%
- Amazon 3.2%▼ −53.0%
- Adobe Inc. 3.1%▼ −26.6%
- Align Technology 2.9%▲ +220.1%
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q1 2019
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| ELV Elevance Health | 10.2% | 6,194,886 | 1.8B USD | +21.5% increased | Q2 2017 8 quarters |
| MSFT Microsoft | 6.6% | 9,773,900 | 1.2B USD | −25.8% reduced | Q2 2016 12 quarters |
| BABA Alibaba Group (ADR) | 6.0% | 5,736,724 | 1.0B USD | −43.7% reduced | Q1 2018 5 quarters |
| UNH UnitedHealth Group | 5.3% | 3,741,036 | 925.0M USD | +31.1% increased | Q4 2016 10 quarters |
| United Technologies Corp | 5.2% | 7,087,162 | 913.5M USD | +1.5% increased | Q3 2017 7 quarters |
| MPC Marathon Petroleum | 4.7% | 13,742,884 | 822.5M USD | +3.8% increased | Q2 2018 4 quarters |
| NFLX Netflix | 4.1% | 1,999,376 | 712.9M USD | −34.0% reduced | Q3 2015 15 quarters |
| AMZN Amazon | 3.2% | 311,719 | 555.1M USD | −53.0% reduced | Q2 2015 16 quarters |
| ADBE Adobe Inc. | 3.1% | 2,042,188 | 544.2M USD | −26.6% reduced | Q4 2018 2 quarters |
| ALGN Align Technology | 2.9% | 1,795,990 | 510.7M USD | +220.1% increased | Q4 2018 2 quarters |
| V Visa Inc. | 2.8% | 3,074,793 | 480.3M USD | −49.8% reduced | Q3 2016 11 quarters |
| Biomarin Pharmaceutical Inc | 2.6% | 5,128,909 | 455.6M USD | +0.7% increased | Q1 2018 5 quarters |
| GOOGL Alphabet Inc. (Class A) | 2.5% | 374,627 | 440.9M USD | −51.7% reduced | Q4 2015 14 quarters |
| Berry Global Group Inc | 2.4% | 7,721,681 | 416.0M USD | +40.0% increased | Q3 2018 3 quarters |
| Liberty Media Corp Delaware | 2.3% | 11,670,116 | 409.0M USD | +7.2% increased | Q1 2017 9 quarters |
| ILMN Illumina, Inc. | 2.1% | 1,182,324 | 367.3M USD | +3.4% increased | Q2 2018 4 quarters |
| Wellcare Health Plans Inc | 2.0% | 1,320,404 | 356.2M USD | +135.6% increased | Q4 2018 2 quarters |
| META Meta Platforms | 2.0% | 2,129,299 | 354.9M USD | −55.6% reduced | Q1 2016 13 quarters |
| JD JD.com (ADR) | 2.0% | 11,552,547 | 348.3M USD | new | Q1 2019 1 quarter |
| MRNA Moderna | 1.9% | 16,667,866 | 339.2M USD | −2.4% reduced | Q4 2018 2 quarters |
| NVDA Nvidia | 1.9% | 1,885,334 | 338.5M USD | new | Q1 2019 1 quarter |
| TMO Thermo Fisher Scientific | 1.8% | 1,146,037 | 313.7M USD | +109.2% increased | Q4 2017 6 quarters |
| MELI MercadoLibre | 1.8% | 611,869 | 310.7M USD | new | Q1 2019 1 quarter |
| Exact Sciences Corp | 1.6% | 3,214,982 | 278.5M USD | −18.8% reduced | Q3 2018 3 quarters |
| DIS Walt Disney Company (The) | 1.4% | 2,172,157 | 241.2M USD | −35.8% reduced | Q1 2018 5 quarters |
| NXPI NXP Semiconductors | 1.4% | 2,725,389 | 240.9M USD | new | Q1 2019 1 quarter |
| Activision Blizzard Inc | 1.3% | 4,909,367 | 223.5M USD | new | Q1 2019 1 quarter |
| CNC Centene Corporation | 1.3% | 4,198,726 | 223.0M USD | +118.4% increasedafter 2:1 stock split | Q2 2018 4 quarters |
| GOOG Alphabet Inc. (Class C) | 0.9% | 137,642 | 161.5M USD | −9.9% reduced | Q4 2018 2 quarters |
| DVA DaVita | 0.9% | 2,755,505 | 149.6M USD | +5.5% increased | Q4 2018 2 quarters |
| ALL Allstate | 0.8% | 1,543,256 | 145.3M USD | new | Q1 2019 1 quarter |
| Covetrus Inc | 0.7% | 3,889,937 | 123.9M USD | new | Q1 2019 1 quarter |
| BSX Boston Scientific | 0.7% | 3,220,369 | 123.6M USD | −38.1% reduced | Q3 2018 3 quarters |
| FANG Diamondback Energy | 0.7% | 1,137,514 | 115.5M USD | −24.9% reduced | Q4 2018 2 quarters |
| Syneos Health Inc | 0.7% | 2,219,074 | 114.9M USD | +26.3% increased | Q1 2018 5 quarters |
| AON Aon plc | 0.6% | 654,224 | 111.7M USD | +24.9% increased | Q3 2018 3 quarters |
| Crown Holdings Inc | 0.6% | 2,025,899 | 110.6M USD | new | Q1 2019 1 quarter |
| BKNG Booking Holdings | 0.6% | 59,671 | 104.1M USD | new | Q1 2019 1 quarter |
| Mylan N V | 0.6% | 3,583,269 | 101.6M USD | +85.7% increased | Q3 2018 3 quarters |
| Hess Corp | 0.6% | 1,641,021 | 98.8M USD | new | Q1 2019 1 quarter |
| MU Micron Technology | 0.5% | 2,289,892 | 94.6M USD | new | Q1 2019 1 quarter |
| Jazz Pharmaceuticals PLC | 0.5% | 635,736 | 90.9M USD | −30.7% reduced | Q1 2017 9 quarters |
| Middleby Corp | 0.5% | 622,493 | 80.9M USD | +0.4% increased | Q2 2018 4 quarters |
| PGR Progressive Corporation | 0.5% | 1,105,895 | 79.7M USD | −68.0% reduced | Q3 2018 3 quarters |
| Zendesk Inc | 0.4% | 863,786 | 73.4M USD | −39.4% reduced | Q4 2018 2 quarters |
| ZBH Zimmer Biomet | 0.4% | 521,466 | 66.6M USD | new | Q1 2019 1 quarter |
| Anaptysbio Inc | 0.3% | 830,160 | 60.6M USD | +11.3% increased | Q1 2018 5 quarters |
| Burlington Stores Inc | 0.3% | 342,079 | 53.6M USD | new | Q1 2019 1 quarter |
| LYB LyondellBasell | 0.3% | 633,235 | 53.2M USD | new | Q1 2019 1 quarter |
| Blueprint Medicines Corp | 0.3% | 658,661 | 52.7M USD | −45.1% reduced | Q3 2018 3 quarters |
| Eidos Therapeutics Inc | 0.3% | 1,986,201 | 46.6M USD | unchanged | Q2 2018 4 quarters |
| Catalent Inc | 0.2% | 1,060,513 | 43.0M USD | −32.8% reduced | Q1 2018 5 quarters |
| Gallagher Arthur J & Co | 0.2% | 475,830 | 37.2M USD | −60.4% reduced | Q1 2018 5 quarters |
| Editas Medicine Inc | 0.1% | 931,401 | 22.8M USD | unchanged | Q1 2016 13 quarters |
| Axa Equitable HLDGS Inc | < 0.1% | 681,600 | 13.7M USD | new | Q1 2019 1 quarter |
| Nevro Corp | < 0.1% | 112,414 | 7.0M USD | new | Q1 2019 1 quarter |
| Atyr Pharma Inc | < 0.1% | 3,209,955 | 1.8M USD | +131.9% increased | Q3 2017 7 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Breakdown by sector
- Health Care 27.5%
- Technology 13.6%
- Communication Services 11.0%
- Energy 5.4%
- Financials 4.7%
- Consumer Discretionary 3.8%
- Materials 0.3%
- not in our coverage 33.8%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors